Survival rates for leukopneumonia depend on the severity of the disease and the presence of complications, and can generally be around 1%-80%. White Lung Disease, also known as atypical pneumonia, is an acute infectious disease of the respiratory system caused by infection to the SARS coronavirus. This disease lacks specific treatment and generally prefers individual treatment. In the treatment process, patients are treated according to their different physical differences, and the appropriate treatment measures are taken for different conditions. The main clinical focus is on symptomatic treatment and treatment for complications. The treatment principle remains early detection, early isolation and early treatment. If there are more serious complications, such as lung abscess, meningitis, or even respiratory distress syndrome, which affects the stability of vital signs and leads to cardiopulmonary failure, the patient may die at any time and the survival rate is very low. If the condition improves with timely treatment and good cardiopulmonary function can be ensured, the survival time of patients will be longer and can reach the same survival rate as normal people, reaching more than 80%.